Tetraphase Pharmaceuticals
IPOWatertown, United States · Founded 2006 · $103.0M raised
- Headquarters
- Watertown, Massachusetts
- Employees
- 51–200
- Founded
- 2006
- Business Model
- B2B
- Website
- tetraphase.com
- Total Funding
- $103.0M
- Last Round
- $8.0M Corporate RoundNov 2019
- Rounds
- 4
About
Tetraphase Pharmaceuticals was a biopharmaceutical company that developed novel antibiotics for critical care and infectious diseases using its proprietary fully synthetic tetracycline chemistry platform. Its lead product XERAVA (eravacycline), a fluorocycline antibiotic, was FDA-approved in August 2018 for treatment of complicated intra-abdominal infections caused by susceptible gram-positive and gram-negative bacteria.
Summary
Tetraphase Pharmaceuticals is a Biotech company based in Watertown, United States, founded in 2006. It has raised $103.0M in total across 4 rounds, most recently a $8.0M Corporate Round round in Nov 2019. Investors include Excel Venture Management, Mediphase Venture Partners and Bay City Capital.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Nov 2019
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...